Delong Sun
Chief Operating OfficerMr. Delong Sun is Chief Operating Officer of TransThera Sciences (Nanjing), Inc. from June 12, 2026. Mr. Sun is responsible for the overall commercial operations of TransThera Sciences (Nanjing), Inc. Mr. Sun possesses over 20 years of extensive experience in the biopharmaceutical industry, with capabilities to manage the full spectrum of business, from front-line pharmaceutical marketing and academic promotion to overall corporate operations. Prior to joining the Company, Mr. Sun served as the chief operating officer of Jiangsu Simcere Medical Diagnostics Co. Ltd. from June 2023 to February 2026 and was responsible for the comprehensive management of the company. From December 2021 to May 2023, he served as the deputy general manager of Liaoning Herbpex Pharmaceutical (Group) Co. Ltd. and the general manager of Liaoning Herbpex Group Pharmaceutical Co. Ltd., responsible for the overall management and operations of such companies. From July 2006 to December 2021, Mr. Sun worked at Jiangsu Simcere Pharmaceutical Co. Ltd., where he successively served as the regional manager of Northeast China, head of national sales, executive director of the group and general manager of the Beijing branch; among which, he served as the executive director of the group from 2017 to December 2021. Mr. Sun holds a bachelor's degree in pharmacy from Shenyang Pharmaceutical University.
Positions
- Company NameTransThera Sciences (Nanjing), Inc.Stock Code02617PositionChief Operating OfficerColleagues
- YWYongqian WuFounder, CEO & Chairman
- DWDi WuPresident, Financial Controller & Executive Director
- SCSongxi CuiVice President of Operations
- JFJing FanChief Medical Officer
- SPShu Pai LiIndependent Non-Executive Director
- HYHoi Yam ChuiIndependent Non-Executive Director
- WZWeili ZhaoEmployees Representative Chairwoman of Supervisory Board
